Richard D Carvajal Selected Research

gp100 Melanoma Antigen

7/2019

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Carvajal Research Topics

Disease

70	Neoplasms (Cancer) 10/2022 - 12/2006
69	Melanoma (Melanoma, Malignant) 03/2022 - 04/2010
34	Uveal melanoma 10/2022 - 04/2011
12	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2013
8	Disease Progression 01/2021 - 04/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 06/2012
6	Fatigue 01/2021 - 01/2009
6	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 05/2012
5	Nausea 01/2021 - 12/2009
4	Diarrhea 01/2021 - 01/2009
4	Fever (Fevers) 01/2021 - 01/2019
4	Neutropenia 04/2015 - 01/2009
3	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2018
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2019 - 03/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
2	Exanthema (Rash) 01/2021 - 01/2018
2	Vomiting 01/2021 - 12/2009
2	COVID-19 01/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2019 - 06/2015
2	Carcinogenesis 06/2019 - 07/2012
2	Hypertension (High Blood Pressure) 08/2017 - 11/2015
2	Hypersensitivity (Allergy) 01/2017 - 08/2010
2	Brain Neoplasms (Brain Tumor) 07/2015 - 05/2015
2	Colorectal Neoplasms (Colorectal Cancer) 06/2012 - 11/2010
2	Hyponatremia 04/2011 - 12/2009
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

16	IpilimumabIBA 01/2021 - 04/2010
12	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2011
10	Immune Checkpoint InhibitorsIBA 01/2021 - 04/2014
10	Monoclonal AntibodiesIBA 01/2021 - 04/2014
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2019 - 09/2011
8	AZD 6244IBA 01/2018 - 07/2012
6	pembrolizumabIBA 04/2021 - 01/2016
6	NivolumabIBA 01/2021 - 04/2014
6	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 06/2014
6	Biological ProductsIBA 01/2021 - 03/2012
6	alvocidib (flavopiridol)IBA 11/2012 - 01/2009
5	tebentafuspIBA 10/2022 - 07/2019
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2010
5	Imatinib Mesylate (Gleevec)FDA Link 06/2019 - 05/2011
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2022 - 06/2011
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022 - 07/2019
3	Phosphotransferases (Kinase)IBA 10/2022 - 12/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	AntigensIBA 02/2021 - 06/2013
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 06/2015
3	Protein Kinase CIBA 01/2020 - 10/2013
3	AntibodiesIBA 11/2019 - 06/2013
3	LigandsIBA 11/2019 - 06/2012
3	Mitogen-Activated Protein KinasesIBA 01/2016 - 10/2013
3	Docetaxel (Taxotere)FDA Link 11/2015 - 01/2009
3	B7-H1 AntigenIBA 03/2015 - 06/2013
2	tremelimumabIBA 01/2022 - 10/2021
2	durvalumabIBA 01/2022 - 10/2021
2	CytokinesIBA 01/2022 - 01/2021
2	sotrastaurinIBA 11/2021 - 01/2020
2	LY3022855IBA 10/2021 - 01/2021
2	EnzymesIBA 01/2021 - 04/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Arginine (L-Arginine)FDA Link 01/2021 - 04/2013
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2018
2	talimogene laherparepvecIBA 06/2020 - 10/2017
2	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 04/2019
2	VemurafenibIBA 10/2019 - 07/2015
2	Peptides (Polypeptides)IBA 07/2019 - 04/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 07/2019 - 08/2010
2	nilotinib FDA Link 06/2019 - 05/2015
2	Dasatinib (BMS 354825)FDA Link 06/2019 - 06/2017
2	Tyrosine Kinase InhibitorsIBA 06/2019 - 05/2015
2	PLX51107IBA 01/2019 - 01/2019
2	ontuxizumabIBA 01/2018 - 03/2015
2	Gemcitabine FDA Link 11/2015 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 06/2015 - 06/2015
2	Temozolomide (Temodar)FDA LinkGeneric 06/2015 - 06/2014
2	PlatinumIBA 04/2015 - 12/2009
2	Carboplatin (JM8)FDA LinkGeneric 04/2015 - 06/2012
2	Alkaline PhosphataseIBA 04/2015 - 12/2011
2	CTLA-4 AntigenIBA 01/2015 - 01/2014
2	GTP-Binding Proteins (G-Protein)IBA 08/2014 - 07/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2012 - 11/2010
2	MitogensIBA 07/2012 - 09/2011
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 04/2011
1	c-Mer Tyrosine KinaseIBA 10/2022
1	sitravatinibIBA 10/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	spartalizumabIBA 01/2022
1	AlpelisibIBA 11/2021

Therapy/Procedure

55	Therapeutics 03/2022 - 12/2006
18	Immunotherapy 04/2021 - 06/2013
12	Drug Therapy (Chemotherapy) 03/2022 - 06/2013
6	Radiotherapy 01/2020 - 06/2010
2	Secondary Prevention 01/2020 - 01/2018
2	Neoadjuvant Therapy 04/2019 - 11/2015
2	Drug Tapering 01/2019 - 01/2009
2	Investigational Therapies (Experimental Therapy) 01/2018 - 11/2013
2	Aftercare (After-Treatment) 01/2016 - 04/2014
1	Adjuvant Chemotherapy 01/2022